195 related articles for article (PubMed ID: 29473040)
1. Direct Immunofluorescence Using Non-Lesional Buccal Mucosa in Mucous Membrane Pemphigoid.
Kamaguchi M; Iwata H; Ujiie I; Ujiie H; Sato J; Kitagawa Y; Shimizu H
Front Med (Lausanne); 2018; 5():20. PubMed ID: 29473040
[TBL] [Abstract][Full Text] [Related]
2. Anti-BP180-type mucous membrane pemphigoid: report of two cases.
Wada M; Sato J; Shindoh M; Ujiie H; Natsuga K; Nishie W; Shimizu H; Kitagawa Y
Odontology; 2016 Jan; 104(1):114-8. PubMed ID: 25355555
[TBL] [Abstract][Full Text] [Related]
3. Autoantibody Detection for Diagnosis in Direct Immunofluorescence-Negative Mucous Membrane Pemphigoid: Ocular and Other Sites Compared.
Dart J; Setterfield J; Groves RW; Mee JB; Diercks GFH; Pas HH; Minassian D;
Ophthalmology; 2021 Mar; 128(3):372-382. PubMed ID: 32745569
[TBL] [Abstract][Full Text] [Related]
4. Assessment of Diagnostic Strategy for Mucous Membrane Pemphigoid.
Rashid H; Meijer JM; Diercks GFH; Sieben NE; Bolling MC; Pas HH; Horvath B
JAMA Dermatol; 2021 Jul; 157(7):780-787. PubMed ID: 33909024
[TBL] [Abstract][Full Text] [Related]
5. In vitro organ culture model for mucous membrane pemphigoid.
Colón JE; Bhol KC; Razzaque MS; Ahmed AR
Clin Immunol; 2001 Feb; 98(2):229-34. PubMed ID: 11161979
[TBL] [Abstract][Full Text] [Related]
6. Bullous pemphigoid antigen II (BP180) and its soluble extracellular domains are major autoantigens in mucous membrane pemphigoid: the pathogenic relevance to HLA class II alleles and disease severity.
Oyama N; Setterfield JF; Powell AM; Sakuma-Oyama Y; Albert S; Bhogal BS; Vaughan RW; Kaneko F; Challacombe SJ; Black MM
Br J Dermatol; 2006 Jan; 154(1):90-8. PubMed ID: 16403100
[TBL] [Abstract][Full Text] [Related]
7. A spontaneous canine model of mucous membrane (cicatricial) pemphigoid, an autoimmune blistering disease affecting mucosae and mucocutaneous junctions.
Olivry T; Dunston SM; Schachter M; Xu L; Nguyen N; Marinkovich MP; Chan LS
J Autoimmun; 2001 Jun; 16(4):411-21. PubMed ID: 11437489
[TBL] [Abstract][Full Text] [Related]
8. Analysis of antigens targeted by circulating IgG and IgA antibodies in patients with mucous membrane pemphigoid predominantly affecting the oral cavity.
Carrozzo M; Cozzani E; Broccoletti R; Carbone M; Pentenero M; Arduino P; Parodi A; Gandolfo S
J Periodontol; 2004 Oct; 75(10):1302-8. PubMed ID: 15562906
[TBL] [Abstract][Full Text] [Related]
9. Multiple and repeated sampling increases the sensitivity of direct immunofluorescence testing for the diagnosis of mucous membrane pemphigoid.
Shimanovich I; Nitz JM; Zillikens D
J Am Acad Dermatol; 2017 Oct; 77(4):700-705.e3. PubMed ID: 28676329
[TBL] [Abstract][Full Text] [Related]
10. [Cicatricial pemphigoid--an important differential diagnosis in inflammatory mucous membrane changes].
Baier G; Zillikens D
Laryngorhinootologie; 1999 Nov; 78(11):632-7. PubMed ID: 10615658
[TBL] [Abstract][Full Text] [Related]
11. Assessment of Diagnostic Strategy for Early Recognition of Bullous and Nonbullous Variants of Pemphigoid.
Meijer JM; Diercks GFH; de Lang EWG; Pas HH; Jonkman MF
JAMA Dermatol; 2019 Feb; 155(2):158-165. PubMed ID: 30624575
[TBL] [Abstract][Full Text] [Related]
12. Immune-mediated subepithelial blistering diseases of mucous membranes. Pure ocular cicatricial pemphigoid is a unique clinical and immunopathological entity distinct from bullous pemphigoid and other subsets identified by antigenic specificity of autoantibodies.
Chan LS; Yancey KB; Hammerberg C; Soong HK; Regezi JA; Johnson K; Cooper KD
Arch Dermatol; 1993 Apr; 129(4):448-55. PubMed ID: 7682049
[TBL] [Abstract][Full Text] [Related]
13. The optimal oral biopsy site for diagnosis of mucous membrane pemphigoid and pemphigus vulgaris.
Carey B; Joshi S; Abdelghani A; Mee J; Andiappan M; Setterfield J
Br J Dermatol; 2020 Mar; 182(3):747-753. PubMed ID: 31021396
[TBL] [Abstract][Full Text] [Related]
14. Detection of linear IgE deposits in bullous pemphigoid and mucous membrane pemphigoid: a useful clue for diagnosis.
Yayli S; Pelivani N; Beltraminelli H; Wirthmüller U; Beleznay Z; Horn M; Borradori L
Br J Dermatol; 2011 Nov; 165(5):1133-7. PubMed ID: 21711326
[TBL] [Abstract][Full Text] [Related]
15. Comparative study of direct and indirect immunofluorescence and of bullous pemphigoid 180 and 230 enzyme-linked immunosorbent assays for diagnosis of bullous pemphigoid.
Sárdy M; Kostaki D; Varga R; Peris K; Ruzicka T
J Am Acad Dermatol; 2013 Nov; 69(5):748-753. PubMed ID: 23969034
[TBL] [Abstract][Full Text] [Related]
16. Immunofluorescence testing in the diagnosis of autoimmune blistering diseases: overview of 10-year experience.
Arbache ST; Nogueira TG; Delgado L; Miyamoto D; Aoki V
An Bras Dermatol; 2014; 89(6):885-9. PubMed ID: 25387492
[TBL] [Abstract][Full Text] [Related]
17. Enzyme-linked immunosorbent assay (ELISA) and indirect immunofluorescence testing in a bullous pemphigoid and pemphigoid gestationis.
Barnadas MA; Rubiales MV; González MJ; Puig L; García P; Baselga E; Pujol R; Alomar A; Gelpí C
Int J Dermatol; 2008 Dec; 47(12):1245-9. PubMed ID: 19126009
[TBL] [Abstract][Full Text] [Related]
18. Immunofluorescence serration pattern analysis as a diagnostic criterion in antilaminin-332 mucous membrane pemphigoid: immunopathological findings and clinical experience in 10 Dutch patients.
Terra JB; Pas HH; Hertl M; Dikkers FG; Kamminga N; Jonkman MF
Br J Dermatol; 2011 Oct; 165(4):815-22. PubMed ID: 21692774
[TBL] [Abstract][Full Text] [Related]
19. Clinical and diagnostic features of mucous membrane pemphigoid.
Endo H; Rees TD; Kuyama K; Kono Y; Yamamoto H
Compend Contin Educ Dent; 2006 Sep; 27(9):512-6; quiz 517-8. PubMed ID: 17052040
[TBL] [Abstract][Full Text] [Related]
20. Laboratory Diagnosis and Clinical Profile of Anti-p200 Pemphigoid.
Meijer JM; Diercks GF; Schmidt E; Pas HH; Jonkman MF
JAMA Dermatol; 2016 Aug; 152(8):897-904. PubMed ID: 27167149
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
